150 related articles for article (PubMed ID: 17874283)
21. Michaelis-Menten metabolite formation kinetics: equations relating area under the curve and metabolite recovery to the administered dose.
Chow AT; Jusko WJ
J Pharm Sci; 1990 Oct; 79(10):902-6. PubMed ID: 2280360
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of various models of hyaluronan kinetics for assessment of liver function.
Lindqvist U; Groth T; Lebel L
Scand J Clin Lab Invest; 1997 Feb; 57(1):49-58. PubMed ID: 9127457
[TBL] [Abstract][Full Text] [Related]
23. An Analytical Approach of One-Compartmental Pharmacokinetic Models with Sigmoidal Hill Elimination.
Wu X; Zhang H; Li J
Bull Math Biol; 2022 Sep; 84(10):117. PubMed ID: 36100829
[TBL] [Abstract][Full Text] [Related]
24. Refinement of the population pharmacokinetic model for the monoclonal antibody matuzumab: external model evaluation and simulations.
Kuester K; Kovar A; Lüpfert C; Brockhaus B; Kloft C
Clin Pharmacokinet; 2009; 48(7):477-87. PubMed ID: 19691369
[TBL] [Abstract][Full Text] [Related]
25. Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation: II. Michaelis-Menten kinetics.
Gonda I
J Pharmacokinet Biopharm; 1984 Oct; 12(5):525-34. PubMed ID: 6520746
[TBL] [Abstract][Full Text] [Related]
26. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.
Rubin GM; Waschek JA; Pond SM; Effeney DJ; Tozer TN
J Pharmacokinet Biopharm; 1987 Dec; 15(6):615-31. PubMed ID: 3450845
[TBL] [Abstract][Full Text] [Related]
27. Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.
Wu X; Nekka F; Li J
J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):447-59. PubMed ID: 27405818
[TBL] [Abstract][Full Text] [Related]
28. Explicit solution of integrated 1 - exp equation for predicting accumulation and decline of concentrations for drugs obeying nonlinear saturation kinetics.
Keller F; Hartmann B; Czock D
Ther Drug Monit; 2009 Dec; 31(6):783-5. PubMed ID: 19881403
[TBL] [Abstract][Full Text] [Related]
29. Application of the two-compartment open model with Michaelis-Menten elimination kinetics to valproic acid in the bile-exteriorized rat.
Lawyer CH; Gerber N; Lynn RK; Dickinson RG
Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):469-84. PubMed ID: 6770426
[TBL] [Abstract][Full Text] [Related]
30. On the identification of Michaelis-Menten elimination parameters from a single dose-response curve.
Godfrey KR; Fitch WR
J Pharmacokinet Biopharm; 1984 Apr; 12(2):193-221. PubMed ID: 6491901
[TBL] [Abstract][Full Text] [Related]
31. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
Rubin GM; Tozer TN
J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
[TBL] [Abstract][Full Text] [Related]
32. Shortcut formulae for pharmacokinetic dosage adjustments.
Belloto RJ
Clin Pharmacokinet; 2009; 48(9):555-60. PubMed ID: 19725590
[TBL] [Abstract][Full Text] [Related]
33. Optimal control of drug therapy: melding pharmacokinetics with viral dynamics.
Yang Y; Xiao Y; Wang N; Wu J
Biosystems; 2012 Mar; 107(3):174-85. PubMed ID: 22172775
[TBL] [Abstract][Full Text] [Related]
34. Fractal michaelis-menten kinetics under steady state conditions: Application to mibefradil.
Marsh RE; Tuszyński JA
Pharm Res; 2006 Dec; 23(12):2760-7. PubMed ID: 17063399
[TBL] [Abstract][Full Text] [Related]
35. Analysis program based on finite element method, MULTI(FEM), for evaluation of dose-dependent local disposition of drug in liver.
Fukumura K; Yamaoka K; Higashimori M; Nakagawa T
J Pharm Sci; 1999 May; 88(5):538-43. PubMed ID: 10229646
[TBL] [Abstract][Full Text] [Related]
36. Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.
Wagner JG
Clin Pharmacokinet; 1985; 10(5):432-42. PubMed ID: 3899457
[TBL] [Abstract][Full Text] [Related]
37. Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability.
Wagner JG
Clin Pharmacol Ther; 1985 May; 37(5):481-7. PubMed ID: 3987171
[TBL] [Abstract][Full Text] [Related]
38. Exact solutions and equi-dosing regimen regions for multi-dose pharmacokinetics models with transit compartments.
Hof F; Bridge LJ
J Pharmacokinet Pharmacodyn; 2021 Feb; 48(1):99-131. PubMed ID: 33040255
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent pharmacokinetics of probenecid in the rat.
Emanuelsson BM; Paalzow LK
Biopharm Drug Dispos; 1988; 9(1):59-70. PubMed ID: 3342285
[TBL] [Abstract][Full Text] [Related]
40. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
Wagner JG; Szpunar GJ; Ferry JJ
J Pharmacokinet Biopharm; 1985 Feb; 13(1):73-92. PubMed ID: 4020623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
